Cargando…

Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System

PURPOSE: Stereotactic magnetic resonance image–guided adaptive radiation therapy (SMART) is an emerging technique that shows promise in the treatment of pancreatic cancer and other abdominopelvic malignancies. However, it is unknown whether the time-limited nature of on-table adaptive planning may r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Phillip E., Chu, Fang-I., Agazaryan, Nzhde, Cao, Minsong, Tyran, Margeurite, Yang, Yingli, Low, Daniel, Raldow, Ann, Lee, Percy, Steinberg, Michael, Lamb, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056223/
https://www.ncbi.nlm.nih.gov/pubmed/33898868
http://dx.doi.org/10.1016/j.adro.2021.100682
_version_ 1783680608294141952
author Chow, Phillip E.
Chu, Fang-I.
Agazaryan, Nzhde
Cao, Minsong
Tyran, Margeurite
Yang, Yingli
Low, Daniel
Raldow, Ann
Lee, Percy
Steinberg, Michael
Lamb, James M.
author_facet Chow, Phillip E.
Chu, Fang-I.
Agazaryan, Nzhde
Cao, Minsong
Tyran, Margeurite
Yang, Yingli
Low, Daniel
Raldow, Ann
Lee, Percy
Steinberg, Michael
Lamb, James M.
author_sort Chow, Phillip E.
collection PubMed
description PURPOSE: Stereotactic magnetic resonance image–guided adaptive radiation therapy (SMART) is an emerging technique that shows promise in the treatment of pancreatic cancer and other abdominopelvic malignancies. However, it is unknown whether the time-limited nature of on-table adaptive planning may result in dosimetrically suboptimal plans. The purpose of this study was to quantitatively address that question through systemic retrospective replanning of treated on-table adaptive pancreatic cancer cases. METHODS AND MATERIALS: Of 74 consecutive adapted fractions, 30 were retrospectively replanned based on deficiencies in planning target volume (PTV) and gross tumor volume (GTV) coverage or doses to organs-at-risk (OARs) that exceeded ideal constraints. Retrospective plans were created by adjusting dose-volume objectives in an iterative fashion until deemed optimized. The goal of replanning was to improve PTV/GTV coverage while keeping the dose to gastrointestinal OARs the same or lower or to reduce OAR doses while keeping PTV coverage the same or higher. The global maximum dose was required to be maintained within 2% of that of the treated adaptive plan to eliminate it as a confounding factor. A threshold of 5% improvement in PTV coverage or 5% decrease in OAR dose was used to define a clinically significant improvement. RESULTS: Of the 30 replans, 7 obtained at least 5% PTV coverage improvement. The average increase in PTV coverage for these plans was 11%. No plans were clinically significantly improved in terms of OAR sparing. Changes in beam-on time did not show any correlation. Statistical analysis via a linear mixed-effects model with a nested random effect suggested that both GTV and PTV coverage were improved over SMART process plans by 0.91 cc (P = .02) and 2.03 cc (P < .001), respectively. CONCLUSIONS: Dosimetric plan quality of at least 10% of SMART fractions may be improved through more extensive replanning than is currently performed on-table. Further work is needed to develop an automated replanning workflow to streamline the in-depth replanning process to better fit into an on-table adaptive workflow.
format Online
Article
Text
id pubmed-8056223
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80562232021-04-23 Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System Chow, Phillip E. Chu, Fang-I. Agazaryan, Nzhde Cao, Minsong Tyran, Margeurite Yang, Yingli Low, Daniel Raldow, Ann Lee, Percy Steinberg, Michael Lamb, James M. Adv Radiat Oncol Scientific Article PURPOSE: Stereotactic magnetic resonance image–guided adaptive radiation therapy (SMART) is an emerging technique that shows promise in the treatment of pancreatic cancer and other abdominopelvic malignancies. However, it is unknown whether the time-limited nature of on-table adaptive planning may result in dosimetrically suboptimal plans. The purpose of this study was to quantitatively address that question through systemic retrospective replanning of treated on-table adaptive pancreatic cancer cases. METHODS AND MATERIALS: Of 74 consecutive adapted fractions, 30 were retrospectively replanned based on deficiencies in planning target volume (PTV) and gross tumor volume (GTV) coverage or doses to organs-at-risk (OARs) that exceeded ideal constraints. Retrospective plans were created by adjusting dose-volume objectives in an iterative fashion until deemed optimized. The goal of replanning was to improve PTV/GTV coverage while keeping the dose to gastrointestinal OARs the same or lower or to reduce OAR doses while keeping PTV coverage the same or higher. The global maximum dose was required to be maintained within 2% of that of the treated adaptive plan to eliminate it as a confounding factor. A threshold of 5% improvement in PTV coverage or 5% decrease in OAR dose was used to define a clinically significant improvement. RESULTS: Of the 30 replans, 7 obtained at least 5% PTV coverage improvement. The average increase in PTV coverage for these plans was 11%. No plans were clinically significantly improved in terms of OAR sparing. Changes in beam-on time did not show any correlation. Statistical analysis via a linear mixed-effects model with a nested random effect suggested that both GTV and PTV coverage were improved over SMART process plans by 0.91 cc (P = .02) and 2.03 cc (P < .001), respectively. CONCLUSIONS: Dosimetric plan quality of at least 10% of SMART fractions may be improved through more extensive replanning than is currently performed on-table. Further work is needed to develop an automated replanning workflow to streamline the in-depth replanning process to better fit into an on-table adaptive workflow. Elsevier 2021-03-03 /pmc/articles/PMC8056223/ /pubmed/33898868 http://dx.doi.org/10.1016/j.adro.2021.100682 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Scientific Article
Chow, Phillip E.
Chu, Fang-I.
Agazaryan, Nzhde
Cao, Minsong
Tyran, Margeurite
Yang, Yingli
Low, Daniel
Raldow, Ann
Lee, Percy
Steinberg, Michael
Lamb, James M.
Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System
title Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System
title_full Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System
title_fullStr Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System
title_full_unstemmed Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System
title_short Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System
title_sort dosimetric quality of online adapted pancreatic cancer treatment plans on an mri-guided radiation therapy system
topic Scientific Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056223/
https://www.ncbi.nlm.nih.gov/pubmed/33898868
http://dx.doi.org/10.1016/j.adro.2021.100682
work_keys_str_mv AT chowphillipe dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT chufangi dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT agazaryannzhde dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT caominsong dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT tyranmargeurite dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT yangyingli dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT lowdaniel dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT raldowann dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT leepercy dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT steinbergmichael dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem
AT lambjamesm dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem